Celgene and Novartis Pharmaceuticals Sue Actavis

  • November 13, 2011

Celgene and Novartis Pharmaceuticals filed suit against Actavis over six patents related to drug formulations having diminished abuse potential.  11/4, District of New Jersey, 2:2011cv06519.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×